The Division of neuropathology at Johns Hopkins is committed to diagnosing and curing diseases affecting the brain. With the explosion in knowledge of basic neurobiology and the advances in understanding of the genetic, molecular and cellular bases of diseases, there has been no time of greater promise for discovering how to treat patients suffering from conditions affecting the nervous system.
For any clinician or patient questions:
Faculty SpotLight
Jonathan Ling, Ph.D.
Dr. Ling is an Assistant Professor of Pathology at The Johns Hopkins School of Medicine. His research combines bioinformatics and genetic engineering to develop therapeutic strategies for age-related neurodegenerative diseases and monogenic disorders. He employs large-scale computational analyses of next-generation sequencing data to identify novel disease mechanisms, with the goal of translati... Read full bio
Browse All FacultyDonald L. Price Memorial Symposium
Donald Price was the founder and Director of the Division of Neuropathology at Johns Hopkins and the leader of the Neuropathology Laboratory and the Alzheimer’s Disease Research Center for many years. He made seminal contributions to translational neurology and neuropathology, especially on molecular mechanisms and animal models of neurodegenerative disorders such as Alzheimer’s disease and amyotrophic lateral sclerosis, and on brain aging. Don’s influence on the training and careers of many scientists has been profound and is a major part of his legacy.
The Donald L. Price Memorial Symposium will be held on November 10, 2023 at the Chevy Chase Auditorium from 9:00 am to 4:00 pm.
Keynote Speakers:
Stanley Prusiner, M.D. - University of California San Francisco Weill Institute for Neurosciences and Institute for Neurodegenerative Diseases
Don W. Cleveland, Ph.D. - Cellular and Molecular Medicine (CMM) University of California San Diego
For more details, download the brochure and program.
Optional webinar for virtual viewing of the symposium will also be available. Participants must register below to receive the zoom link.
New study by Dr. Cherry Ho on COVID and smell in JAMA Neurology
Our new faculty member Dr. Cherry Ho just published an exciting study online in JAMA Neurology. She and her colleagues find that inflammation-caused nerve damage weakens odor signals to the brain.
Anosmia, the loss of smell, is a frequent and often long-term symptom associated with COVID-19 that can severely burden a person’s quality of life, making it extremely difficult to taste foods, detect airborne hazards in the environment and carry out other functions dependent on the sense.
New neuropathology faculty member Cheng-Ying (Cherry) Ho
We are excited to announce that Dr. Ho joined our faculty in January 2022 as an Associate Professor. She received her M.D. from National Taiwan University (2003) and a Ph.D. from Columbia University in New York (2009). Her subsequent AP/NP training was at Johns Hopkins, followed by faculty positions at George Washington University and the University of Maryland School of Medicine. Her clinical work will include general autopsy and eye pathology. Her research studies, currently supported by a K08, focus on diabetic neuropathy.